Treatment in the form of RAS blockers has not been very effective so far in some patients, especially in African Americans (33% of this population has hypertension), in whom high arterial blood pressure is accompanied by low levels of renin (decrease in systemic RAS activity), high levels of vasopressin, and susceptibility to salt in the diet. This evidence concerns the gene REN and hypertensive disorder.